Samsung Biologics
Get verified emails for Samsung Biologics employeesAbout Samsung Biologics
Samsung Biologics is a fully integrated contract development and manufacturing organization (CDMO) that provides contract development and manufacturing services for biologics products. Strong capabilities matter here. It supports biopharmaceutical companies through every stage of the development and manufacturing process, with state-of-the-art capabilities and proven regulatory approvals.
Founded in 2011 and based in Songdo, Incheon, Republic of Korea, the company serves biopharmaceutical companies worldwide. Samsung Biologics is described as having the largest capacity and fastest throughput, and it employs between 1,001 and 5,000 people.
Need to reach the Samsung Biologics team directly? Find verified work emails for every employee with Snov.io
Insights
Updated 31 Aug 2026Samsung Biologics is moving to strengthen its position in the global CDMO market through a 3 trillion KRW capital increase tied to an acquisition of Polypeptide Group. The plan points to an expansion strategy built around inorganic growth, and investors are comparing the company with other Korean biotech names that have recently seen mixed stock reactions to financing events.
Fresh equity is being used to fund a strategic acquisition, which suggests the company wants to broaden its competitive reach beyond its core contract development and manufacturing base. The market is watching closely. In the near term, the key question is whether this step will improve Samsung Biologics’ standing in the increasingly competitive CDMO landscape, where scale and capability expansion are key differentiators.
Investor sentiment has been negative in the short run. Samsung Biologics shares fell 6.78% after the rights offering was announced, according to market coverage of the broader biotech move, and that reaction suggests investors are cautious about dilution and execution risk even as the company pursues a larger strategic footprint.
Frequently asked questions
Samsung Biologics is headquartered in Songdo, Incheon, Korea (Republic of).
Samsung Biologics has 1001-5000 employees according to its company profile.
Samsung Biologics operates in the Pharmaceuticals sector. Public valuation figures are not always disclosed for private companies.